Market News & Trends
Aptalis to be Acquired by Forest Laboratories for $2.9 Billion
Aptalis recently announced that it has signed a definitive agreement to be acquired by Forest Laboratories, Inc. Forest has agreed to acquire Aptalis from TPG,…
Revamped Therapies Preventing Visual Impairment Primed to Revolutionize US Retinal Therapeutics Market
The need for effective and patient-friendly treatment of retinal diseases to avoid visual impairment is driving the retinal therapeutics market in the US. Vascular endothelial…
FDA Endorses, Pushes for Abuse-Resistant Opioid Formulations: Transition to Disrupt Pain Market
The opioid market is dominated by non-tamper-resistant formulations (TRFs), but the FDA’s promotion of TRF therapies could well result in the departure of non-TRF therapies…
Merck Plans Radical Overhaul of R&D Unit
Merck & Co. Inc. is working on a plan to radically reshape its once-storied R&D unit that would create international innovation hubs tapping into drug…
Encap Announces Collaboration With Lipocine
Encap Drug Delivery, part of Capsugel’s Dosage Form Solutions (DFS) business unit, recently announced a collaboration with Lipocine Inc. to manufacture Phase III clinical trial…
New Report on Global Markets for Advanced Drug Delivery Systems
According to a new technical market research report, Global Markets and Technologies for Advanced Drug Delivery Systems, from BCC Research (http://www.bccresearch.com), the global market for…
DNAnexus, Inc. Secures $15 Million in Financing, Led by Google Ventures
DNAnexus recently announced it has closed a $15-million Series C funding led by Claremont Creek Ventures, Google Ventures, TPG Biotech, and First Round Capital. The…
Scioderm Initiates Phase IIB Study
Scioderm, Inc. recently announced the initiation of a Phase IIB study designed to evaluate the efficacy and safety of SD-101, a novel topical therapy, for…
Unilife Signs Agreement With Global Pharma Company Seeking to Use Ocu-Ject
Unilife Signs Agreement With Global Pharma Company Seeking to Use Ocu-Ject Unilife Corporation recently announced the signing of an agreement with a global pharmaceutical…
Lightlake Therapeutics Joint Clinical Trial With NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose to be Promising
Lightlake Therapeutics Inc. recently announced the initial findings of its clinical trial with the National Institute on Drug Abuse (NIDA), part of the National Institutes…
Adocia Signs Exclusive Nanotechnology License
Adocia recently announced the signature of an exclusive license agreement with the CNRS, the University Bordeaux I, the Institut Polytechnique de Bordeaux and Aquitaine Science…
Monoclonal Antibodies Market for Colorectal Cancer to Witness Moderate Growth, as Late-Stage Pipeline Remains Weak
The market value for monoclonal antibodies (mAbs) in colorectal cancer treatment will experience a moderate increase from $3.7 billion in 2012 to $5.2 billion by…
Antitope Enters Research Agreement with Annexon to Generate Novel Therapeutic Antibodies
Antitope Ltd recently announced it has entered a research agreement with Annexon to generate novel antibody therapeutics for the treatment of neurodegenerative diseases. Under the…
Peptineo Inks Exclusive Option for Drug Delivery Technologies
Peptineo recently announced the company has inked an exclusive option for a broad set of nanotechnology patents in the area of drug delivery from Lawrence…
RBCC & Therakine Initiate Phase II of Revolutionary Delivery Technology
Rainbow Coral Corp. and its joint venture partner, Therakine, Ltd., recently announced they have reached a major new milestone in the development of a revolutionary…
Kytosan USA Looks to Become Market Leader for Domestic Chitosan
Under an exclusive patent licensing agreement from its parent, KYTOSAN USA will produce and market high-quality industrial-grade chitosan, a specialty chemical made from discarded crustacean…
Unilife Announces Clinical Supply Agreement With Novartis
Unilife recently announced an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with one…
Hovione’s New Inhalation Capsule Filling Machine Fills Market Gap
Hovione recently announced the expansion of its inhalation drug product development services with the introduction of a high-precision MG2 FlexaLAB capsule filling machine. This investment…
The Three Big Predictions for the Global Healthcare Market
Frost & Sullivan recently released its three big predictions for the global healthcare market. Based on a 2013 Search for Growth survey that involved 1835…
Foster Introduces Online Polymer Purchases for Medical Device Product Development
Foster Polymer Distribution, a business unit of Foster Corporation that specializes in distribution of medical grade polymers, recently announced the introduction of a new website…
